Hematopoietic Akt2 deficiency attenuates the progression of atherosclerosis
-
- Noemi Rodlan
- Vascular Biology and Therapeutics ProgramYale University School of MedicineNew HavenConnecticutUSA
-
- Aránzazu Chamorro‐Jorganes
- Vascular Biology and Therapeutics ProgramYale University School of MedicineNew HavenConnecticutUSA
-
- Elisa Araldi
- Vascular Biology and Therapeutics ProgramYale University School of MedicineNew HavenConnecticutUSA
-
- Amarylis C. Wanschel
- Departments of MedicineLeon H. Charney Division of Cardiology, and Cell BiologyNew York University School of MedicineNew YorkNew YorkUSA
-
- Binod Aryal
- Vascular Biology and Therapeutics ProgramYale University School of MedicineNew HavenConnecticutUSA
-
- Juan F. Aranda
- Vascular Biology and Therapeutics ProgramYale University School of MedicineNew HavenConnecticutUSA
-
- Leigh Goedeke
- Vascular Biology and Therapeutics ProgramYale University School of MedicineNew HavenConnecticutUSA
-
- Alessandro G. Salerno
- Departments of MedicineLeon H. Charney Division of Cardiology, and Cell BiologyNew York University School of MedicineNew YorkNew YorkUSA
-
- Cristina M. Ramírez
- Vascular Biology and Therapeutics ProgramYale University School of MedicineNew HavenConnecticutUSA
-
- William C. Sessa
- Vascular Biology and Therapeutics ProgramYale University School of MedicineNew HavenConnecticutUSA
-
- Yajaira Suárez
- Vascular Biology and Therapeutics ProgramYale University School of MedicineNew HavenConnecticutUSA
-
- Carlos Fernández‐Hernando
- Vascular Biology and Therapeutics ProgramYale University School of MedicineNew HavenConnecticutUSA
収録刊行物
-
- The FASEB Journal
-
The FASEB Journal 29 (2), 597-610, 2014-11-12
Wiley